buzz, the longer term thesis you posit has validity…but so did the longer term views from 6 months ago, a year ago, two years ago…I think you get the drift. The IDIQ comes thru and bingo! the goal posts get moved yet again due to Morpho's official protest which delays any action on the contract until TSA resolves and revenue won't hit the books until the fourth fiscal quarter in April. Maybe in FQ3, but thats not reported until May 15. So the balance sheet remains in the crapper until then with a need for financing prior. Meanwhile, we still don't see the ETD contracts going Implant's way. So forgive me my frustrations but there have been rosy scenarios for the last four years here. On what terms will they refinance? my educated guess, based on experience in these markets is close to the price we are at right now. How much premium would someone be willing to pay considering the debt and fully diluted share count? Perhaps the answer will be beneficial to us but until then the water is murky and that usually means no one goes fishing. And it sure would have been a bone to throw his long suffering shareholders if Bolduc went out and promoted the stock a bit to bring in some new money. Why he expects us to provide liquidity indefinitely while they get their fat salaries and options is….well, fill in the blank. And please don't patronize us, we all know the "value" here. thats why we're still here.
b9molecule
News 
Market Data 
Discover 
AI
